Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 17/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | BCL6 | P41182 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7692930 | 0.83 | AURKA (0.45) | AURKASYKCYP3A4TSHRRECQL | |
| SCHEMBL7702493 | 0.81 | AURKA (0.46) | AURKACYP3A4TSHRRECQL | |
| SCHEMBL7688852 | 0.75 | GRM5 (0.55) | AURKACYP3A4TSHRRECQLL3MBTL1 | |
| SCHEMBL7694335 | 0.71 | EGFR (0.52) | — | |
| SCHEMBL7691603 | 0.71 | RAB9A (0.43) | — | |
| SCHEMBL16960488 | 0.68 | MAPT (0.52) | AURKACYP3A4TSHRRECQLL3MBTL1 | |
| SCHEMBL25083596 | 0.67 | JAK2 (0.36) | BCL6 | |
| SCHEMBL7688350 | 0.66 | AURKA (0.46) | AURKASYKCYP3A4TSHRRECQL | |
| SCHEMBL440145 | 0.65 | MAPT (0.57) | CYP3A4TSHRRECQLL3MBTL1 | |
| SCHEMBL7684002 | 0.65 | TUBB4A (0.49) | AURKACYP3A4RECQLL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011163355-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-12-29 | — | — | WO | disclosed |